International Patent: SALTS OF (S)-1-(1-(3-CHLOROPHENYL)-2-(DIMETHYLAMINO)ETHYL)-4-(5-MORPHOLINO-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)PYRIDIN-2(1H)-ONE FOR USE IN THE TREATMENT OF MELANOMA WITH BRAF V600 MUTATION

GENEVA, July 27 -- IPSEN PHARMA filed a patent application (EP2026/050758) for “SALTS OF (S)-1-(1-(3-CHLOROPHENYL)-2-(DIMETHYLAMINO)ETHYL)-4-(5-MORPHOLINO-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)PYRIDIN-2(1H)-ONE FOR USE IN THE TREATMENT OF MELANOMA WITH BRAF V600 MUTATION”. With publication no. WO/2026/153964, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/5377

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....